Overview

Trazodone Once a Day in Major Depression Disorder

Status:
Completed

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

Summary

The study objective is to evaluate the efficacy and safety of trazodone OAD vs venlafaxine extended release (venlafaxine XR) after an 8-week treatment period in patients with major depressive disorder.

Phase:

Phase 3

Details

Lead Sponsor:

Aziende Chimiche Riunite Angelini Francesco S.p.A

Treatments:

Trazodone
Venlafaxine Hydrochloride